There is a paucity of strong evidence associated with adverse pregnancy outcomes and
thrombophilia in pregnancy. These problems include both early (recurrent miscarriage) and …

Background Very high blood pressure during pregnancy poses a serious threat to women
and their babies. The aim of antihypertensive therapy is to lower blood pressure quickly but …

Objective To present an approach, based on current evidence, for the diagnosis, treatment,
and thromboprophylaxis of venous thromboembolism in pregnancy and postpartum …

Background Placenta-mediated pregnancy complications include pre-eclampsia, late
pregnancy loss, placental abruption, and birth of a small-for-gestational-age (SGA) neonate …

Background Since hypercoagulability might result in recurrent miscarriage, anticoagulant
agents could potentially increase the chance of live birth in subsequent pregnancies in …

Background Thrombophilias are common disorders that increase the risk of pregnancy-
associated venous thromboembolism and pregnancy loss and can also increase the risk of …

Background: Early‐onset hypertensive disorders (HD) of pregnancy and small‐for‐
gestational age infants (SGA) are associated with placental vascular thrombosis, these often …

Background Evidence on the impact of low-molecular-weight heparin, alone or in
combination with low-dose aspirin, for the prevention for preeclampsia in high-risk patients …

A 35-year-old woman with recurrent severe placenta-mediated pregnancy complications in
her 2 pregnancies asks: Will low-molecular-weight heparin help prevent recurrent placenta …

Objective To estimate the impact of adding low‐molecular‐weight heparin (LMWH) or
unfractionated heparin to low‐dose aspirin started≤ 16 weeks' gestation on the prevalence …